| Literature DB >> 35230694 |
David T Melnekoff1, Alessandro Laganà2.
Abstract
Single-cell sequencing technologies are revolutionizing cancer research and are poised to become the standard for translational cancer studies. Rapidly decreasing costs and increasing throughput and resolution are paving the way for the adoption of single-cell technologies in clinical settings for personalized medicine applications. In this chapter, we review the state of the art of single-cell DNA and RNA sequencing technologies, the computational tools to analyze the data, and their potential application to precision oncology. We also discuss the advantages of single-cell over bulk sequencing for the dissection of intra-tumor heterogeneity and the characterization of subclonal cell populations, the implementation of targeted drug repurposing approaches, and describe advanced methodologies for multi-omics data integration and to assess cell signaling at single-cell resolution.Entities:
Keywords: CNV; Cell-cell signaling; Drug repurposing; Intra-tumor heterogeneity; Pathway analysis; SNV; Single-cell sequencing; scDNA-seq; scRNA-seq
Mesh：
Year: 2022 PMID： 35230694 DOI： 10.1007/978-3-030-91836-1_15
Source DB: PubMed Journal: Adv Exp Med Biol ISSN： 0065-2598 Impact factor: 2.622